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suggest a dominant inheritance pat-
tern. Interestingly, in contrast with 
other mutations, the R1459C mutation 
is localized extremely close to the car-
boxy-terminal end of the ABCC6 pro-
tein and leaves all functional sites of 
the protein apparently intact.
Thirdly, if pseudodominance explains 
all cases of putative dominant inheri-
tance in PXE (up to 10%), the carrier 
frequency of PXE must be much high-
er than previously anticipated. This 
conclusion seems to be supported by 
recent findings: calculations on the 
basis of mutation analysis in ABCC6 
suggest a heterozygote frequency for 
PXE of 1.25%–3.0% (Chassaing et al., 
2005). If this theoretical figure is cor-
rect, then the number of (homozy-
gous) PXE patients actually observed 
in populations is unexpectedly low, if 
they are in Hardy–Weinberg equilib-
rium. Chassaing et al. (2005) suggested 
that one explanation could be that a 
number of sequence variations in the 
ABCC6 gene would not lead to PXE at 
all. Indeed, the putative functional role 
of “neutral” ABCC6 polymorphisms, if 
any, has yet to be established. A number 
of so-called neutral variants may con-
tribute to ABCC6 function, dysfunction, 
and pathogenicity, especially in combi-
nation with more “severe” mutations. 
The existence of “mild” and “severe” 
pathogenic variants was also previously 
suggested for the ABCC6 family mem-
ber ABCC7 (Welsh and Smith, 1993) 
and ABCR (Yatsenko et al., 2001). On 
the other hand, this hypothesis was pre-
viously tested and rejected for ABCC6 
in families from The Netherlands, 
because of high intrafamiliar variation 
in the PXE phenotype (Hu et al., 2003).
Fourth, thoroughly investigated 
multigeneration pedigrees in human 
genetics are rare, which may partly 
explain why most PXE families are only 
described in two generations.
Finally, the influence of diet and 
other environmental factors on the PXE 
phenotype in patients and carriers is 
still poorly understood.
In summary, within the limitations 
given above, the current hypothesis is 
that PXE is an autosomal recessive dis-
ease. The recent construction of PXE 
mouse models, in which targeted loss 
of function of abcc6 causes PXE-like 
symptoms, further supports that notion 
(Gorgels et al., 2005; Klement et al., 
2005). These conclusions and findings 
probably mark the end of the autoso-
mal dominant PXE segregation myth.
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Langerhans Cells on Guard in the 
Epidermis: Poised to dSEARCH and . . .?
Mark C. Udey1
Langerhans cells have long been considered to be prototypic immature den-
dritic cells. Results of experiments involving genetically engineered mice pro-
vide surprising new insights into Langerhans cell function in vivo. Nishibu and 
colleagues illustrate how these approaches can be used to visualize Langerhans 
cells in vivo in real time, and to assess aspects of their behavior in unperturbed 
skin and after activation.
Journal of Investigative Dermatology (2006) 126, 705–707. doi:10.1038/sj.jid.5700222
Although immune responses involve 
entire organisms, studies of immunity 
during the past several decades have 
emphasized, and perhaps overempha-
sized, reductionist in vitro experiments. 
Recently, the pendulum has swung back, 
and publication of novel results of in 
vitro experiments in high-profile journals 
essentially requires that authors demon-
strate that their results are physiological-
ly relevant. Although the bar has clearly 
moved up in this regard, the facility with 
which unambiguous in vivo experiments 
can be conducted and interpreted has 
also increased considerably.
The increased ease with which infor-
mative in vivo experiments can be car-
ried out reflects increases in the knowl-
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dSEARCH (dendrite surveillance extension and 
retraction cycling habitude) 
connotes the regular 
extension of LC dendrites 
between keratinocytes.
edge bases of immunology and genetics, 
as well as specific methodologic and 
technologic advances that have occurred 
in parallel. Development of the ability to 
manipulate the mouse genome almost 
at will has been critical. Genes of inter-
est (such as those encoding cytokines) 
can now be expressed in a geographi-
cally and temporally restricted fashion 
in transgenic mice with the use of induc-
ible or constitutively active, lineage- or 
tissue-selective promoters. Alternatively, 
gene “knock-in” approaches can be used 
to insert genes of interest downstream of 
endogenous regulatory regions, antici-
pating that maximum fidelity of expres-
sion will be achieved. Applications of 
transgenic mouse technology allow cells 
to be selectively “marked” with readily 
detectable proteins such as β-galacto-
sidase or enhanced green fluorescent 
protein (EGFP), and even selectively 
targeted for destruction. Finally, genes 
of interest can be selectively and consti-
tutively knocked out in mice by disrup-
tion of genes in embryonic stem cells via 
homologous recombination, or deleted 
in postnatal life using inducible promo-
ters and Cre-lox technology.
The availability of increasingly sophis-
ticated, minimally perturbing, intra vital 
microscopic imaging technologies that 
allow observation of cell behaviors in 
situ has also been incredibly impor-
tant (Halin et al., 2005; Germain et al., 
2005). Successful and informative visu-
alization of leukocyte–endothelial cell 
interactions in superficial or exteriorized 
blood vessels spurred interest in devel-
oping additional instrumentation that 
would permit leukocytes in other tissues 
to be studied. Using confocal and/or 
multiphoton fluorescence microscopy, it 
is now possible to image appropriately 
labeled cells in the subcapsular regions 
of lymph nodes and in thin tissues such 
as corneal epithelia and skin. Both tis-
sue explants and vital tissues have been 
studied using these approaches.
Because of their importance and their 
essential roles in initiating and propagat-
ing T cell-dependent immune responses, 
dendritic cells (DCs) (including epider-
mal Langerhans cells (LCs)) are among 
the cells that have been actively stud-
ied by these recently developed in vivo 
approaches. DCs have been successfully 
imaged in lymph nodes, and the dynam-
ics of DC–T cell interactions have been 
documented in real time (Germain and 
Jenkins, 2004). The recent identifica-
tion of the C-type lectin Langerin as an 
LC-selective marker and characteriza-
tion of the Langerin gene have afforded 
scientists the opportunity to study LCs in 
situ and to begin to definitively elucidate 
their function(s) (Valladeau and Saeland, 
2005). Although prototypic in the sense 
that they have been studied more exten-
sively than other DCs, LCs appear to rep-
resent a sublineage of DCs that are dis-
tinct from both interstitial and plasmacy-
toid DCs. Absolute dependence on trans-
forming growth factor-β1 for development 
and/or localization, the ability to persist 
in normal epidermis for months at a time, 
and derivation from slowly cycling local 
precursors are properties that differenti-
ate LCs from other DCs, including inter-
stitial DCs in the dermis (Valladeau and 
Saeland, 2005). It has been difficult to 
assign unique functional activities to LCs 
as compared with dermal DCs, however.
Recently, two groups of investigators 
independently created strains of mice 
in which complementary DNAs encod-
ing closely related diptheria toxin recep-
tor–EGFP fusion proteins were knocked 
into endogenous Langerin loci, albeit in 
slightly different positions and in differ-
ent embryonic stem cells (Kissenpfennig 
et al., 2005; Bennett et al., 2005). 
Transgenic mice derived from these cells 
were viable and otherwise normal, and 
epidermal LCs uniformly expressed diph-
theria toxin receptor–EGFP. Generation 
of corresponding Langerin–EGFP knock-
in mice (Kissenpfennig et al., 2005) 
allowed straightforward identification of 
LCs and related cells, as well as prelimi-
nary studies of LC behavior in explants 
and in situ, and tracking of LCs into lym-
phoid tissues after initiation of contact 
sensitivity responses. These investigations 
revealed that “resting” LCs are sessile 
and become motile after application of a 
strong inflammatory stimulus (for exam-
ple, tape stripping) (Kissenpfennig et al., 
2005). Tracking studies revealed that, 
after application of a contact allergen, 
dermal DCs migrated to draining lymph 
nodes more quickly than epidermal LCs, 
and, somewhat surprisingly, that LCs and 
dermal DCs localized in adjacent but 
distinct regions of the T cell-rich paracor-
tex (Kissenpfennig et al., 2005).
A third group of investigators has 
generated a related transgenic mouse in 
which expression of diptheria toxin itself 
is driven by human Langerin upstream 
regulatory sequences (Kaplan et al., 
2005). In these mice, it is likely that LCs 
are deleted as soon as the Langerin pro-
moter becomes active. This contrasts 
with mice described by Kissenpfennig 
et al. (2005) and Bennett and co-work-
ers (2005), in which LCs are deleted only 
after systemic injection of diptheria toxin, 
a toxin that kills only cells that have been 
engineered to express the diptheria toxin 
receptor and does not perturb cells that 
are negative for this receptor. Systemic 
depletion of LCs began within hours 
after introduction of diptheria toxin, was 
virtually complete by 2 days, and lasted 
for several weeks or more (Kissenpfennig 
et al., 2005; Bennett et al., 2005).
Contact hypersensitivity (CHS) 
responses to allergenic small molecules 
such as trinitrochlorobenzene, oxazo-
lone, and DNFB in mice have long been 
an experimental model of choice for in 
vivo studies of skin immune responses. 
Many papers have implicated LCs as 
key accessory cells in CHS responses, 
and direct presentation of hapten to 
naive T cells in draining lymph nodes 
by skin-derived LCs has been the pre-
ferred paradigm. Although it has been 
conjectured that LCs play similar roles 
in more complex skin immune respons-
es, recent studies in murine models of 
cutaneous herpes simplex virus infec-
tion (Allan et al., 2003) and leishmania-
sis (Ritter et al., 2004) suggest that DCs 
other than LCs may be directly involved 
in antigen presentation to effector T 
cells. The ability to study CHS respons-
es in mice with isolated LC deficits has 
allowed a more rigorous assessment 
of the requirement for participation of 
LCs in this model. Studies of CHS reac-
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tions in the three different LC-deficient 
mouse models reported to date have 
led to results that are simultaneously 
congruous and disparate.
Depletion of LCs did not abrogate 
CHS responses in any of the three strains 
studied. Whereas Kissenpfennig et al. 
(2005) reported that CHS responses 
were equivalent in LC-deficient and LC-
replete mice, Bennett et al. (2005) noted 
that they were attenuated, and Kaplan 
et al. (2005) determined that they were 
enhanced. Because these studies were 
performed in different laboratories, the 
experimental procedures varied to some 
extent, and the differences reported were 
quantitatively modest, it is difficult to 
determine which result is “most correct.” 
If the differences reported are confirmed 
in side-by-side comparisons using iden-
tical conditions and blinded observers, 
elucidation of the mechanism(s) respon-
sible for the differences may provide 
important new insights into LC function. 
For the time being, however, at least we 
can say that LCs are not essential for 
CHS responses. This conclusion is very 
interesting in itself.
This issue of the Journal contains 
another elegant example of studies of 
epidermal LCs in situ. Transgenic mice 
and sophisticated imaging methods 
again feature prominently in the experi-
ments. Akiko Nishibu, working with his 
colleagues in Akira Takashima’s group 
at the University of Texas Southwestern 
Medical Center, has systematically cata-
logued the behavior of murine LCs in 
skin explants and in vivo, both in the 
presence and in the absence of inflam-
matory signals (tumor necrosis factor-α 
or contact allergen administration) that 
activate LCs and mobilize them from 
skin to draining lymph nodes (Nishibu 
et al., 2006). Nishibu et al. used mice in 
which a complementary DNA encoding 
EGFP was knocked into the I-Aβ chain 
locus. Although I-Aβ is not a specific 
marker for LCs, in normal or acutely 
inflamed epidermis essentially all I-Aβ-
expressing cells are LCs. Using time-
lapse confocal microscopy and obser-
vation periods extending for several 
hours, the investigators could assess the 
location of cells in four dimensions, and 
locations of LC dendrites and cell bod-
ies could be followed with relative ease 
(Nishibu et al., 2006).
The paper by Nishibu et al. confirms 
that resting LCs are sessile and that 
application of inflammatory stimuli 
(explanting of skin or injection of tumor 
necrosis factor-α) induces both lateral 
and vertical motility of cell bodies, as 
reported by Kissenpfennig et al. (2005), 
and ultimately exit from the epidermis. 
Nishibu and co-workers also docu-
ment, for the first time, an LC behavior 
that they term “dSEARCH” (dendrite 
surveillance extension and retraction 
cycling habitude) (Nishibu et al., 2006). 
dSEARCH connotes the regular exten-
sion of LC dendrites between keratino-
cytes. In the absence of perturbation, 
only 5%–10% of epidermal LCs engage 
in dSEARCH. However, dSEARCH 
activity increases dramatically with 
regard to the frequency with which 
dendrites are extended and retracted, 
and the amplitude of the projections in 
tissue explants or in skin that has been 
injected with tumor necrosis factor-α 
or painted with DNFB. At this juncture, 
it is not possible to determine whether 
the LCs that exhibited dSEARCH with-
out provocation were more “mature” 
than the others (perhaps because they 
had been in residence in the epidermis 
for the longest period of time) or if they 
were perhaps responding to subclini-
cal inflammation.
Many of us who have looked at LCs 
in epidermal sheets using conventional 
immunofluorescence microscopy have 
wondered whether dendrites of adja-
cent LCs abut each other. This ques-
tion is addressed directly by Nishibu 
et al. (2006). They report that although 
contact between adjacent resting LCs 
was rarely observed, contact between 
LCs was readily detected after appli-
cation of maturation stimuli. These 
observations, when considered in the 
aggregate, suggest that LCs do indeed 
function as epidermal sentinels, sur-
veying their environment and possibly 
communicating with each other by 
“touching” after activation. In light of 
the somewhat surprising results of the 
CHS experiments in LC knockout mice 
(Kaplan et al., 2005; Kissenpfennig et 
al., 2005; Bennett et al., 2005), we are 
left wondering what these LCs may be 
telling each other, and possibly rethink-
ing the roles that they play in skin-cen-
tered immune responses.
Although recent experiments leave us 
with many questions, several things are 
very clear. First, increased understand-
ing of LC function in vivo will come 
only from additional in vivo experi-
ments. Second, the various LC-deficient 
mice that have been generated will be 
invaluable in these experiments. Finally, 
new experimental systems and more 
sophisticated imaging technology may 
be required. At the conclusion of the 
recent 9th International Workshop on 
Langerhans Cells, organized by Niki 
Romani and Georg Stingl and held in 
Madeira, Ralph Steinman predicted that, 
in light of emerging new information, 
the next LC meeting, in Bern in 2007, 
will be very interesting. I agree with Dr. 
Steinman, and I am already looking for-
ward to that meeting.
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